The power of sharing lived experiences is key to creating positive changes in health care. MISSD is pleased to release our first podcast in a series called “Akathisia Stories.” Please listen, learn & share here.
A recent study published in the JAMA Internal Medicine journal suggests the risk for dementia is strongest for certain classes of anticholinergic drugs — particularly antidepressants, bladder antimuscarinics, antipsychotics and antiepileptic drugs.
For the full article, click here.
It’s often difficult for pregnant or breastfeeding women to obtain data regarding the safe use of prescription drugs, particularly given it can take more than 20 years to collect reliable safety info on drugs after they come to market. An international effort is underway to improve information in this critical area.
To read the full article, click here.
It was a busy Spring for MISSD and we’re excited to share all our good news as well as our plans for a productive summer of programming and development. This includes a 100K grant, a royal presentation in London and a meaningful podcast series of personal stories all should hear.
Check out the link below for more info!
Today the European Medicines Agency (EMA) announced it is advising that commonly prescribed drugs called selective serotonin re-uptake inhibitors (SSRIs) should carry warnings that about the risks of long term sexual dysfunction as an adverse effect. Prozac, Zoloft and Paxil are just a few of many brand-name SSRIs.
To read the full article, click here.
The veteran suicide rate is at an all-time high and veterans are increasingly over-medicated. Could akathisia awareness prevent many of these deaths? Click here to listen.